FDA On Next Year's Flu Problem


Taariq pritchard

“We’re already partnering with other public health agencies to conduct essential work,” Gottlieb said in a statement released Monday-commissioner by Scott Gotlieb

 The FDA, along with U.S. Centers for Medicare and Medicaid Services, will study millions of flu cases from this year.
The FDA said patients who got a vaccine this year were 25 percent less likely to become sick from influenza A, this year’s deadliest strain.This was almost a 20 percent decrease in effectiveness from last year, according to data from the Centers for Disease Control and Prevention.
It turns out that this year’s vaccine was less effective against influenza A, the common cause of flu-related illnesses this season.